Home Cart Sign in  
Chemical Structure| 2375421-09-1 Chemical Structure| 2375421-09-1

Structure of SR-717
CAS No.: 2375421-09-1

Chemical Structure| 2375421-09-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

SR-717 is a non-nucleotide STING agonist with EC50s of 2.1 μM and 2.2 μM in ISG-THP1 (WT) and ISG-THP1 cGAS KO (cGAS KO) cell lines, respectively. Antitumor activity .

Synonyms: SR 717 (lithium salt)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of SR-717

CAS No. :2375421-09-1
Formula : C15H8F2LiN5O3
M.W : 351.19
SMILES Code : O=C([O-])C1=CC(F)=C(F)C=C1NC(C2=NN=C(N3C=CN=C3)C=C2)=O.[Li+]
Synonyms :
SR 717 (lithium salt)
MDL No. :N/A
InChI Key :ODSAJRWPLSVEHJ-UHFFFAOYSA-M
Pubchem ID :139434658

Safety of SR-717

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
RAW264.7 cells 10.0 µM 24 hours To assess the effect of SH-NPs on macrophage polarization, results showed that SH-NPs significantly reduced the expression of M2 macrophage marker CD206 and increased the expression of M1 macrophage marker CD86. Pharmaceutics. 2024 Sep 17;16(9):1216.
DC2.4 cells 10.0 µM 24 hours To evaluate the cellular uptake and STING pathway activation of SH-NPs, results showed that SH-NPs significantly increased the expression levels of p-TBK1 and p-IRF3 and enhanced IFN-β secretion. Pharmaceutics. 2024 Sep 17;16(9):1216.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Rats Lung ischemia/reperfusion injury model Intraperitoneal injection 3 mg/kg Single dose, 1 hour before surgery Activation of STING aggravated endoplasmic reticulum stress (ERS), leading to increased apoptosis, inflammation, and oxidative stress, thereby exacerbating lung ischemia/reperfusion injury. J Inflamm Res. 2022 Sep 5;15:5103-5119
Mice Periodontitis mouse model Intraperitoneal injection 30 mg/kg Daily dosing for 7 days SR-717-treated periodontitis mice displayed enhanced macrophage infiltration and M1 macrophage polarization in periodontal lesions compared with that in vehicle-treated periodontitis mice Front Microbiol. 2023 Jun 19;14:1183415
BALB/c mice RENCA renal tumor model Intravenous injection 30.0 mg/kg Single injection, observed for 16 days To evaluate the tumor targeting and antitumor efficacy of SH-NPs, results showed that SH-NPs significantly enhanced drug accumulation in tumors and delayed tumor growth, with further improved therapeutic effects when combined with anti-PD-L1 antibody. Pharmaceutics. 2024 Sep 17;16(9):1216.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.85mL

0.57mL

0.28mL

14.24mL

2.85mL

1.42mL

28.47mL

5.69mL

2.85mL

References

 

Historical Records

Categories